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Conclusions: A systematic reduction of air pockets within CTV occurs 
over treatment course. While these anatomical changes don’t affect 
so much the dosimetric outcome in term of OAR irradiation, a not 
negligible degradation of target coverage and dose homogeneity is 
pointed-out. In some cases this degradation couldn’t be clinically 
tolerable. If re-planning is performed on the first control CT the 
stability of dose distributions over the remaining treatment time 
improves.  
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Purpose/Objective: Proton therapy has the potential to deliver a 
superior distribution of radiation dose to the patient compared with 
photon therapy. On the other hand, proton treatments are more 
sensitive to setup variations and anatomical changes. In particular, a 
site where proton therapy could be highly beneficial is lung cancer. 
However, the anatomical changes in lung cancer provide a big 
challenge to deliver the planned dose. As part of the development of 
probabilistic planning systems, where knowledge about geometric 
uncertainties is taken into account during plan optimization, we are 
studying the effect of observed anatomical changes in lung cancer 
patients on scanned beam proton treatments. 
Materials and Methods: We selected three lung cancer patients with 
tumors close to the mediastinum that might be eligible for SBRT with 
protons, while they cannot be delivered with photons due to dose 
limiting constraints. For each patient we had the planning CT and five 
CBCT scans available. We used the research Pinnacle³ Intensity 
Modulated Proton Therapy (IMPT)/Spot Scanning treatment planning 
system (TPS)version 9.100 to create a proton plan for each patient 
using the original planning CT scan. These proton plans were kept very 
simple, consisting of two beams and optimized using the same 
objectives as the photon treatment plan. For every fraction, a CBCT 
was made just before the treatment. These scans represent the 
anatomy of the patient at that particular treatment day. We did not 
consider respiration motion, but used motion compensated CBCT scans 
to describe the 'baseline' anatomical changes. The CBCT scans cannot 
be directly used in the TPS to recalculate the dose as Hounsfield unit 
are not calibrated. Instead,the planning CT scan was deformed to 
every CBCT with in-house software, and dose was next recalculated 
using the original plan in Pinnacle³. The dose differences between the 
planned and delivered proton dose was evaluated 
Results:  
 
PTVmaxdose 
A(PTVmean = 
66.495Gy) 
B (PTVmean = 
66.685Gy) 
C (PTVmean = 
66.685Gy) 
difference 
(Gy) 
relative 
diff (%) 
difference 
(Gy) 
relative 
diff (%) 
difference 
(Gy) 
relative 
diff (%)  
scan1  23.40 -35.19 56.66 -84.91 29.85 -44.77 
scan2 23.84 -35.75 25.65 -38.46 46.50 -69.74 
scan3 26.56 -39.84 25.48 -38.21 44.63 -66.94 
scan4 23.46 -35.28 35.84 -53.75 36.81 -55.21 
scan5 22.35 -33.61 25.71 -38.55 28.26 -42.39 
mean 23.92 -35.93 33.87 -50.79 37.21 -55.81 
standard 
deviation 2.58 2.33 13.49 20.23 8.30 12.45 
 
(table caption: table 1 The maximum dose difference between the 
planningCT and the CBCT scans of the three patients inthe PTV) 
The results in table 1 show a remarkable underdosages in the planning 
treatment volume (PTV) coverage from 36% to 56%. 
Conclusions: Patient anatomy changes occuring during typical lung 
treatments, lead to significant under and overdosage, e.g. the PTV 
underdosages shown in this study. Based on this study, we can 
conclude that classical planning strategies applied for proton therapy 
are unsafe in the lung, and that more advanced planning strategies 
including knowledge of geometrical uncertainties need to be 
developed. 
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Purpose/Objective: To determine and assess the dosimetric 
difference between three emerging treatment modalities, which are 
intensity modulated proton therapy (IMPT), intensity modulated 
carbon ion beam therapy (IMIT) and rotational IMRT (VMAT) for two 
tumour sites where selective boosting of the tumour is applied.  
Materials and Methods: The planning study was retrospectively 
performed on each 10 patients with locally advanced head-and-neck 
(H&N) cancer and high-risk prostate cancer (PC). For each patient a 
VMAT plan was generated for the PTVinitial that included LN regions, 
delivering 50 GyE for H&N and 50.4 GyE for PC patients. Furthermore, 
3 separate boost plans (VMAT, IMPT and IMIT) were created to boost 
the PTVboost up to 70 GyE and 78 GyE for H&N and PC cases, 
respectively. Doses to the primary OARs i.e brainstem, myelon, larynx 
and parotid glands were assessed for H&N cases. Additionally, various 
OARs whose sparing can be associated with improved quality of life 
after treatment were delineated. For PC cases doses to bladder, 
rectum as well as femoral heads were analyzed. In order to sum up 
the total doses, dose matrices of the initial VMAT plans and the 
respective boost plans were mapped together. 
Results: H&N cases: The targets goals were easily met, with higher 
median dose found for VMAT+VMAT compared to VMAT+IMPT and 
VMAT+IMIT (58.2 (4.9) GyE, 53.8 (3.9) GyE, 53.4 (1.3) GyE, 
respectively). All the primary OARs were spared the least by the 
VMAT+VMAT method. Mean doses for VMAT+IMPT and VMAT+IMIT was 
approximately 3 GyE lower for contralateral parotis and 1.5 GyE lower 
for larynx comparing to VMAT+VMAT results. Similarly, D2GyE was on 
average 2 GyE lower for myleon and 2.6 GyE lower for brainstem. 
Moreover, no significant difference was detected between VMAT+IMPT 
and VMAT+IMIT. Considering additional OARs a big improvement was 
found for the VMAT+IMIT method especially in sparing the ipsilateral 
cochlea, middle ear, masticator space as well as the base of tongue 
and soft palate. 
PC cases: In terms of target coverage all 3 modalities reached the 
prescribed goals, with slightly higher average median dose to PTVinital 
for the VMAT+VMAT method, 52.3 (3.2) GyE compared to VMAT+IMPT 
and VMAT+IMIT (51.1 (1.7) GyE and 51.2 (1.4) GyE respectively). 
Similarly, V95% was found to be higher for PTVinitial (VMAT+VMAT = 99.1% 
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(0.6), VMAT+IMPT = 97.7% (0.8), VMAT+IMIT = 97.6% (0.8)). Looking at 
OAR sparing, generally VMAT+VMAT was found to be the worst. Mean 
doses were on average 4 GyE higher for rectal wall and 1.5 GyE for 
bladder wall comparing to combined modalities. VMAT+IMPT and 
VMAT+IMIT had similar tendency of sparing OARs, except for V50GyE, 
V60GyE of the rectal wall, where photons in combination with carbons 
were on average better by 2 GyE. 
Conclusions: Looking at target coverage no significant differences was 
observed between the 3 evaluated treatment concepts. However, 
combining particles and photons spares OARs more beneficially 
compared to sole photon treatments. Moreover, a combination of 
carbon ions and photons may result in limiting doses to those 
structures that are associated with better quality of life after therapy. 
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Purpose/Objective: To investigate the combination of photons, 
protons and carbons for an optimal study design for the treatment of 
meningioma. Meningioma lesions frequently show an aggressive local 
growth and a high incidence of tumor recurrences after neurosurgical 
resection. The rapid dose fall-off of particles and the increased RBE of 
carbons could be of potential benefit leading to increased local 
tumorcontrol as a boost or sole treatment modality. 
Materials and Methods: Based on the gross tumor volume (GTV) two 
different planning tumor volumes (PTV) were constructed for 4 
meningioma patients: The initial PTV (PTVinit) treated with 25x2 GyE 
and the boost PTV (PTVBoost) with 3x6 GyE. For the initial clinical 
target volume (CTVinit) a margin of 1 cm was added to the GTV 
adapted to the surrounding tissue. CTVinit plus 3 mm formed PTVinit and 
for PTVBoost the GTV was enlarged by an isotropic margin of 3 mm. 
Different organs at risk (OAR), delineated using pre- and post 
operative MRI information adapted to the planning CT, were 
considered: eyes, optical nerves, chiasm and brainstem.  
Intensity modulated photon plans (IMXT) were created with Monaco 
(V3.0, Elekta) and intensity modulated proton and carbon ion plans 
(IMPT and 12C) using the TPS XiO (V4.41, Elekta-CMS) and TRiP98, 
respectively. For IMXT 6 beams were used for PTVinit plans and 4 
beams for PTVBoost plans. IMPT and 12C treatment plans were created 
assuming fixed beams. Two beams separated by a couch angle of 20-
30° from ipsilateral side were used for PTVinit and two beams from 
cranio-caudal direction for PTVBoost. Using the software CERR (Version 
4.1, May 2012) dose matrices for the following combinations were 
generated: IMXT+ IMXT or IMPT or 12C; IMPT + IMPT or 12C; 12C + 12C. 
Plan quality was analyzed by evaluating conformity and homogeneity 
index (CI, HI) according to ICRU83, V95%, D2% and D50%; D2%, D50% and Vd 
values were investigated for OARs. 
Results: V95% was higher than 95% for all plans but best for 12C . CI was 
worst for IMXTinit with 0.57±0.03 and higher than 0.72 for IMPT and 12C. HI for 12C was 0.04±0.01 and thus 3 times better than for IMXT, for 
both PTVs. OAR sparing for particle therapy was highly couch angle 
and tumor size dependent. No remarkable difference in dose was 
observed for the ipsilateral optical nerve and the chiasm. 12C as single 
technique could reduce D2% to the contralateral optical nerve by 10 
GyE. The mean dose to the contralateral eye was reduced from 
5.0±3.7 GyE for IMXT+IMXT to 3.2±1.9 GyE for IMXT+ IMPT/12C. 
Moreover, IMPT and 12C as sole treatment modality reduced the dose 
to 0 GyE. V20% of the brainstem was higher than 90% using IMXT as 
initial technique and less than 50% when using IMPT and 12C (figure 1). 
 
  
Conclusions: Highly conformal IMPT and 12C plans could be generated 
with a non-gantry scenario. Improved OAR sparing favors sole12C and 
proton plans, which is should be included in future trial design for 
meningioma patients.  
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Purpose/Objective: This study evaluated field-in-field (FIF) tangential 
technique, TomoDirect and helical tomotherapy (HT) in terms of 
target dose homogeneity, conformity and degree of organs-at-risk 
(OARs) sparing. The results provided useful reference to recommend 
optimal treatment strategy for patients, including the consideration of 
left or right side breast cancer and with or without supraclavicular 
fossa (SCF) lymph nodes involvement. 
Materials and Methods: Total of 30 breast cancer patients with SCF 
lymph nodes involvement were recruited and planned by FIF, 
TomoDirect and HT.They were divided equally (n=15) in two arms of 
left and right side group.Conventional field arrangement of SCF field 
and tangential opposing fields were employed for FIF planning with 
subfields using multileaf collimator (MLCs) for shielding hotspots and 
heart (for left breast cancer patients). TomoDirect used three anteior-
oblique fields for the SCF target and seven fields for the chestwall 
target. With the same prescription, target coverage, dose 
homogeneity and conformity were evaluated. Degree of OARs sparing 
was assessed by means of maximum dose, mean dose and various 
dose-volumes parameters. Beam-on-time of the three techniques 
were recorded and compared to evaluate treatment delivery 
efficiency.  
Results: The present dosimetric comparison proved that advanced 
IMRT techniques of tomotherapy had definite target dosimetric 
advantages over FIF technique. HT generally increased low dose 
volumes compared with the other two techniques. This study showed 
that only TomoDirect achieved high degree of OARs sparing with good 
target dose dosimetry. However, there was a significant volume of 
high dose outside the SCF target and the dose distribution was unlikely 
to be satisfactory in TomoDirect. TomoDirect also resulted in higher 
contralateral breast dose when chest target lied across patients' 
midline or on patients with highly concave chest wall. TomoDirect 
required 30% longer treatment delivery time than FIF and HT (p<0.01) 
as greater modulation factor was needed to bring down the higher 
target dose. The presence of cardiac shield on the left-sided breast 
further deteriorated the target coverage as compared to right-sided 
breast using the same FIF technique(p<0.01). 
 
 
 
 
  
 
 
